Biosimilars to Drive Change in Health System Costs

from tHEORetically Speaking: The HealthEconomics.Com Blog at on June 29, 2016 at 11:45AM

Biosimilar acceptance is growing in a number of therapy areas, and can provide physicians and patients with greater access   to advanced treatments while offering budgetary relief. What areas are seeing the most action? How will all of this affect pricing? See more here. (Source:, June 2016)